Translational Development Acquisition (TDACW) Current Assets (2023 - 2026)

Translational Development Acquisition (TDACW) has reported Current Assets for 4 consecutive years, with $104731.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 32.9% year-over-year to $104731.0; the trailing twelve-month figure through Jun 2026 stood at $104731.0 (down 32.9% YoY), and the FY2025 full-year result was $39465.0, down 93.93% from the prior year.
• Current Assets rose to $104731.0 in Q2 2026 per TDACW's latest filing, from $75316.0 in the prior quarter.
• Across five years, Current Assets topped out at $650233.0 in Q4 2024 and bottomed at $2021.0 in Q4 2023.
• Historically, Current Assets has averaged $190480.9 across 4 years, with a median of $92656.5 in 2025.
• The sharpest annual moves came in 2024 and 2025: Current Assets jumped 32073.82% in 2024, then plunged 93.93% in 2025.
• Over 4 years, Current Assets stood at $2021.0 in 2023, then surged by 32073.82% to $650233.0 in 2024, then slumped by 93.93% to $39465.0 in 2025, then jumped by 165.38% to $104731.0 in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $104731.0, $75316.0, and $39465.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.